Once again, the high prevalence of anti-HLA-F IgG (64/69), in contrast to the low prevalence (8/76) of anti-β2m IgG, suggests that HLA-F variants (Face-2, Face-3, and Face-4; Figure 4) are indeed the major immunogenic antigens in RA patients. Here, HLA-F is linked to rheumatoid arthritis.